Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Explore the Venture capital view of the investment process|Andrew Armour,Managing Partner,Chaac Ventures
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Founder and CIO at Catalina Advisors, LLC
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Exploring Apollo's Strategic Shifts and Investment Outlook in Credit Markets | James Zelter, Co-president, Apollo Global Management.
00:10:00
How Kovac Provides Unmatched Support and Freedom for Financial Advisors
00:10:00
Benoist Grossmann Discusses IDInvest's Venture Capital Strategy and Early Career Influences | Benoist Grossmann, Managing Partner, Idinvest Partners.
00:10:00
Eric H on Retail Investment Trends and Opportunities | Erik Hirsch, CEO, Hamilton Lane.
00:10:00
Separating Fact from Fiction in Investments and Stock Exchanges: Thys van Zyl's 2023 Insights | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:10:00
Mangold Insight interviews tech company DLTx, delving into discussions on AI competitiveness with a reference to C3.ai.
00:10:00
Global-Dining, Inc. featured an episode with an executive chef and restaurant owner discussing culinary insights, alongside a mention of Apple CEO Tim Cook.
00:10:00
Arlo Sarmiento's Journey: Building Vivant Corporation into a Powerhouse for Progress | Arlo Sarmiento, CEO, Vivant Corporation.
00:10:00
Keith McKnight Talks Advancements at Dolphin Tungsten Mine on Tasmania’s King Island | Keith McKnight, CEO , Group 6 Metals Ltd.
00:10:00
Update on Asante Gold: Refurbishment Progress and Future Production Expectations
00:10:00
Mediation Tactics: Insights from John Quinn | John B. Quinn - Founding Partner of Quinn Emanuel Urquhart & Sullivan
00:00:00
ONCIMMUNE HOLDINGS PLC - Strategy Update - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings